Susan Spitz - Concepedia

Author

Susan Spitz

Bristol-Myers Squibb (United States)

Also Known As

S Spitz, S. SPITZ, S. Spitz, S.M. Spitz, Susan M Spitz, Susan M. Spitz, Susan Spitz

Publications

897

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)GlaxoSmithKline (United States)Pfizer (United States)Boehringer Ingelheim (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Susan Spitz is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug discovery, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	252
2	Biochemistry	3	3	113
3	Allergy	2	2	104
4	Natural Sciences	1	1	72
5	Cell Biology	1	1	14

Susan Spitz

Publications

841

Citations

H-Index

Page 1

	Year	Citations
Presenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors Dietmar Seiffert, Jodi D. Bradley, Cynthia M. Rominger, Journal of Biological Chemistry	2000	301
Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants Uma Prabhakar, Edward Eirikis, Manjula Reddy, Journal of Immunological Methods CytokineAutoimmune DiseaseAllergyLaboratory ImmunologyMedicine	2004	78
Disubstituted Indazoles as Potent Antagonists of the Integrin α<sub>v</sub>β<sub>3</sub> Douglas G. Batt, Joseph J. Petraitis, Gregory C. Houghton, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceBiochemistryMedicine	1999	72
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated Jeffrey T. Billheimer, Ira B. Dicker, Richard Wynn, Blood	2002	59
2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies) Brad Ackermann, Hendrik Neubert, Nicola Hughes, Bioanalysis	2015	55
Synthesis of phosphonopeptides as thrombin inhibitors Chia‐Lin J. Wang, Thelma L. Taylor, Alfred J. Mical, Tetrahedron Letters Combinatorial ChemistryThrombin InhibitorsMedicinePharmacotherapyPharmacology	1992	49
2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies) An Song, Anita Lee, Fabio Garofolo, Bioanalysis	2016	42
A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted Activity Jonathan Rios‐Doria, Margaret Favata, Kerri Lasky, Frontiers in Oncology	2020	41
2019 White Paper on Recent Issues in Bioanalysis: Chromatographic Assays (Part 1 – Innovation in Small Molecules and Oligonucleotides & Mass Spectrometric Method Development Strategies for Large Molecule Bioanalysis) Christine Fandozzi, Christopher A. Evans, Amanda Wilson, Bioanalysis	2019	39
Glutamyl-γ-boronate Inhibitors of Bacterial Glu-tRNAGln Amidotransferase Carl P. Decicco, David J. Nelson, Ying Luo, Bioorganic & Medicinal Chemistry Letters BiochemistryMechanism Of ActionGlutamyl-γ-boronate InhibitorsInhibitory ActivityDrug Discovery	2001	28

Page 1